Cytomegalovirus Disease Completed Phase 3 Trials for Letermovir (DB12070)
Also known as: Cytomegaloviral disease, unspecified / Cytomegalovirus Infections / Cytomegalovirus infection / Cytomegalovirus infection (disorder) / Cytomegalic inclusion disease / Cytomegaloviral disease / CMV infection / Cytomegaloviral infections
| Indication | Status | Phase |
|---|---|---|
| DBCOND0042800 (Cytomegalovirus Disease) | Completed | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04129398 | MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042) | Prevention |